Company intelligence / Profile preview

PDMS

Craigavon, United Kingdompdms.com ↗

Ownership: Private
Employees: ~300
Development stage: Other

Overview

PDMS was an established UK-based CDMO offering comprehensive pharmaceutical development through commercial-scale manufacturing services. It supported formulation development, process optimization/scale-up, analytical method validation/transfer, packaging design/implementation, inventory management/logistics/distribution for pharma/biotech clients. The business was acquired by Almac Group in 2003 to expand its integrated service offerings.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

Galen Holdings Plc (historical supply agreement post-acquisition)

Beyond the preview

Go deeper on PDMS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PDMS.

Explore the full profile